preview

Limiting Antibiotics

Decent Essays

According to Kumar et al., the prescription pattern in third world countries is “highly variable, depending on…physician preferences, patient demand, and pharmaceutical promotion” (625). Pertaining to antibiotic overuse are health providers’ financial incentives, which encourage antibiotics instead of prescribed drugs (Tomson & Vlad 119; Finch 96) by emotionally, and ethically appealing to individuals with advertisements, as well as pharmacies promoting antibiotics instead of recommending the doctor in order to build their own credibility and generate profit. Although physicians may have a bad name due to their 80% overall antibiotic prescribing rate for viral infections, general practitioners prescribe unknowingly due to a lack of knowledge …show more content…

Owing to doctor’s fear of inadequate treatment, they tend to prescribe multiple dosages in order to save their selves from termination due to ignorance from treating an infection. However, the public is equally at fault since they terminate their course of antibiotic treatment before their course end. Due to individuals’ perception that antibiotics are unnecessary now, antibiotics disengage in destroying bacteria rapidly, which provides enough time for bacteria to begin to resist antibiotics (Aziz 1073). Although limiting antibiotic use in patients may not directly benefit the patient, it benefits the whole society by preventing the development of resistant strains (Aiello et al. 1914). As well, hospital managers and public healthcare are at fault since they tend to focus on different objectives to secure patient health by using cost effective measures to preserve the effectiveness of antibiotics in order to avoid low revenue (Kaier et al. 494). Therefore, in order to reduce consumption while still allowing access is by realigning their financial incentives and prescription by health care …show more content…

Aiming to educate individuals and health care providers about resistant bacteria’s negative influence on their long-term health, Europe launched a project in 2007: Burden of resistance and disease in European nations (Burden) since the Department of Health identified the lack of data on antibiotics (as cited in Kaier et al. 493). In response to this strategy, United Kingdom’s Department of Health and Environment implanted an antimicrobial resistance strategy from March 2013 to 2018 to promote the responsible antibiotic use for animals and humans and to enhance the guidelines of monitoring antibiotic use (as cited in While 345). So far, it seems like Europe’s strategies are far ahead than North America who has not yet executed any strategies to reduce antibiotic resistance despite the heavy usage of antibiotics as mentioned earlier. Finally, new guidelines are in place by Europe’s government: NG15 and KTT9. NG15 states recommendations regarding antibiotic stewardship in organizations, which includes monitoring antibiotics, identifying resistance patterns, and providing feedback to prescribers. KTT9 summarizes evidence gained from antibiotic prescribing which “emphasizes the importance of minimizing antibiotic prescribing and using simple generic antibiotics where possible, thereby reserving broad spectrum antibiotics to treat resistant

Get Access